SkyePharma wins Japanese approval for inhaled Flutiform; SafeShot gathers $9M for injectables biz;

> The Japanese Ministry of Health approved SkyePharma's inhaled asthma treatment Flutiform, giving the company "several million" in milestone payments from its Japanese partner, Kyorin Pharmaceutical. Item

> SafeShot Technologies secured $9 million in financing--$6 million now on top of $3 million from 2012--which it will use to bolster its sterile injectable business. Release

> Researchers at the University of Twente in the Netherlands have developed multifunctional nanocontainers for imaging, targeting and drug release. Story

> Oramed ($ORMP) will participate in Barclays' Israel Biotech Corporate Day in Zurich, Switzerland, this month. Release